Fig. 2From: Redox-driven cardioprotective effects of sodium-glucose co-transporter-2 inhibitors: comparative reviewThe progression of heart disease can be associated with profound metabolic remodeling, mitochondrial dysfunction and disturbed redox homeostasis. These interconnected changes may lead to energy depletion, impaired cardiac function and ultimately heart failure.Back to article page